Zoloft PPHN lawsuit settlement criteria
We are Bob McGrath Law, and we represent Georgia families whose premature infants have suffered Necrotizing Enterocolitis (NEC) after being fed cow's milk-based infant formula, particularly Enfamil products manufactured by Reckitt Benckiser (Mead Johnson). As of 2026, the legal landscape surrounding these cases has shifted dramatically, with thousands of lawsuits consolidated in multidistrict litigation (MDL) in the Northern District of Illinois. Our firm remains at the forefront of this fight, ensuring that Georgia parents have the resources and experienced legal counsel they need to pursue justice for their children.
The NEC Crisis in Georgia NICU Units: Enfamil and Similac Under Fire
Necrotizing Enterocolitis is a devastating gastrointestinal disease that primarily affects premature infants, causing inflammation and death of intestinal tissue. In Georgia, neonatal intensive care units (NICUs) in hospitals like Children's Healthcare of Atlanta and Piedmont have long used cow's milk-based formulas such as Enfamil and Similac. However, mounting evidence—including internal company documents revealed in the ongoing MDL—shows that manufacturers like Reckitt Benckiser knew of the heightened risk of NEC when these formulas were fed to preterm infants, yet failed to warn parents and doctors. The American Academy of Pediatrics has recommended human milk-based products for preterm infants since 2012, but formula companies continued marketing their products as safe alternatives.
"Parents in Georgia deserve to know the truth: Enfamil and Similac have been linked to life-altering NEC injuries in premature babies. We are committed to holding these corporations accountable for their failure to warn. For more information on the ongoing litigation, see the Bob McGrath Law NEC page and the archived case reference."
Reckitt Benckiser Settlement Updates and Georgia Case Milestones
In 2025, Reckitt Benckiser reached a $60 million settlement with the state of Illinois to resolve claims related to Enfamil and NEC, but Georgia families remain outside that deal. The MDL has seen significant progress, with bellwether trials scheduled through 2026. We have tracked the following key milestones for Georgia plaintiffs:
| Milestone | Date | Impact on Georgia Cases |
|---|---|---|
| First MDL bellwether trial (Illinois) | March 2024 | Set precedent for causation evidence; Georgia courts take note |
| Reckitt Benckiser $60M Illinois settlement | June 2025 | Excluded Georgia; state-specific litigation ramps up |
| Georgia Supreme Court ruling on forum non conveniens | October 2025 | Allowed out-of-state plaintiffs to sue in Georgia if formula was fed in GA hospitals |
| Second MDL bellwether trial (Pennsylvania) | January 2026 | Plaintiff verdict of $25M; strengthens Georgia claims |
These developments underscore that Georgia families are not alone. The legal system is beginning to recognize the systemic failure of formula manufacturers to prioritize infant safety over profits.
What Georgia Parents Must Know: Filing an Enfamil NEC Lawsuit in 2026
If your premature infant was diagnosed with NEC after being fed Enfamil or Similac in a Georgia hospital, time is of the essence. Georgia's statute of limitations for personal injury claims is generally two years from the date of injury, but for infants, this clock may not start until the child reaches age 18 in some cases. However, we recommend acting immediately to preserve evidence, including hospital records, formula lot numbers, and feeding logs. Here is what our firm does for every client:
- Case evaluation: We review your child's medical records to confirm the NEC diagnosis and link to cow's milk-based formula feeding.
- Expert witness coordination: We work with neonatologists and epidemiologists to establish causation, citing studies from the Journal of Pediatrics and internal company documents.
- MDL filing: We file your case in the Illinois MDL or Georgia state court, depending on the best venue for your claim.
- Discovery and depositions: We depose Reckitt Benckiser executives and review decades of internal communications showing knowledge of NEC risks.
- Settlement or trial: We pursue maximum compensation for medical expenses, pain and suffering, and lifelong care needs.
The fight for justice is not just about one family—it is about forcing a multibillion-dollar industry to change its practices. Every lawsuit filed in Georgia sends a message that the lives of premature infants are not expendable. We stand ready to take that message to court, and we will not back down until Enfamil and Similac manufacturers are held fully accountable for the harm they have caused.